Jin Yang Pharmaceutical Co. Ltd Market Cap ($32.47 Million)
Market Cap & Net Worth: Jin Yang Pharmaceutical Co. Ltd (007370)
Jin Yang Pharmaceutical Co. Ltd market cap. Jin Yang Pharmaceutical Co. Ltd (KQ:007370) has a market capitalization of $32.47 Million (₩47.92 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23288 globally and #1594 in its home market, demonstrating a -3.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jin Yang Pharmaceutical Co. Ltd's stock price ₩3390.00 by its total outstanding shares 14134587 (14.13 Million). Also see how efficiently does Jin Yang Pharmaceutical Co. Ltd generate cash for how efficiently the company converts equity into cash flow.
Jin Yang Pharmaceutical Co. Ltd Market Cap History (2015–2026)
Jin Yang Pharmaceutical Co. Ltd market cap history from 2015 to 2026. Data shows change from $37.05 Million to $32.47 Million (-2.55% CAGR). Check latest Jin Yang Pharmaceutical Co. Ltd stock price today for real-time trading data and today's change.
Index Memberships
Jin Yang Pharmaceutical Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.02% | #799 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.02% | #799 of 1384 |
Weight: Jin Yang Pharmaceutical Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Jin Yang Pharmaceutical Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jin Yang Pharmaceutical Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Jin Yang Pharmaceutical Co. Ltd growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Jin Yang Pharmaceutical Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Jin Yang Pharmaceutical Co. Ltd's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $42.31 Million | $36.13 Billion | -$9.10 Billion | 0.00x | N/A |
| 2017 | $38.73 Million | $43.45 Billion | -$5.77 Billion | 0.00x | N/A |
| 2018 | $32.56 Million | $46.86 Billion | $933.15 Million | 0.00x | 0.03x |
| 2019 | $39.04 Million | $47.35 Billion | $1.65 Billion | 0.00x | 0.02x |
| 2020 | $63.03 Million | $48.81 Billion | $3.68 Billion | 0.00x | 0.02x |
| 2021 | $64.33 Million | $62.84 Billion | $9.54 Billion | 0.00x | 0.01x |
| 2022 | $60.94 Million | $76.26 Billion | $12.31 Billion | 0.00x | 0.00x |
| 2023 | $59.29 Million | $94.11 Billion | $12.66 Billion | 0.00x | 0.00x |
| 2024 | $55.75 Million | $113.33 Billion | $29.69 Billion | 0.00x | 0.00x |
| 2025 | $48.18 Million | $120.69 Billion | $22.29 Billion | 0.00x | 0.00x |
Competitor Companies of 007370 by Market Capitalization
Companies near Jin Yang Pharmaceutical Co. Ltd in the global market cap rankings as of November 4, 2026. Also see Jin Yang Pharmaceutical Co. Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Jin Yang Pharmaceutical Co. Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Jin Yang Pharmaceutical Co. Ltd (2015–2026)
Market capitalization of Jin Yang Pharmaceutical Co. Ltd from 2015 to today. Between 2015 and today, Jin Yang Pharmaceutical Co. Ltd's market cap moved from $37.05 Million to $ 32.47 Million, with a yearly change of -2.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩32.47 Million | -32.60% |
| 2025 | ₩48.18 Million | -13.57% |
| 2024 | ₩55.75 Million | -5.98% |
| 2023 | ₩59.29 Million | -2.70% |
| 2022 | ₩60.94 Million | -5.26% |
| 2021 | ₩64.33 Million | +2.06% |
| 2020 | ₩63.03 Million | +61.45% |
| 2019 | ₩39.04 Million | +19.89% |
| 2018 | ₩32.56 Million | -15.93% |
| 2017 | ₩38.73 Million | -8.46% |
| 2016 | ₩42.31 Million | +14.20% |
| 2015 | ₩37.05 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Jin Yang Pharmaceutical Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.47 Million USD |
| MoneyControl | $32.47 Million USD |
| MarketWatch | $32.47 Million USD |
| marketcap.company | $32.47 Million USD |
| Reuters | $32.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jin Yang Pharmaceutical Co. Ltd
Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports i… Read more